State MO
Clinical Trials in Missouri
Recruiting clinical trials with at least one study location in Missouri. Data updated daily from ClinicalTrials.gov.
Top Conditions in Missouri
Non-small Cell Lung Cancer (6)Advanced Solid Tumor (5)Metastatic Breast Cancer (5)Cardiovascular Diseases (5)Heart Failure (5)Breast Cancer (5)Head and Neck Squamous Cell Carcinoma (4)Multiple Sclerosis (4)Major Depressive Disorder (3)Atopic Dermatitis (3)Stage IVB Prostate Cancer AJCC v8 (3)Pancreatic Ductal Adenocarcinoma (3)
NCT06397729 N/A
Recruiting
Evaluation of a Novel Technology to Support Tailored Health Behavior Counseling ...
Condition
Cardiovascular Diseases
Enrollment
100 pts
Location
United States
Sponsor
Washington University School o
NCT05982561 N/A
Recruiting
Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive ...
Condition
Bladder Cancer
Enrollment
500 pts
Location
United States
Sponsor
Early is Good Inc.
NCT06524882 Phase 3
Recruiting
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
Condition
Amblyopia
Enrollment
252 pts
Location
United States
Sponsor
Jaeb Center for Health Researc
NCT06470451 Phase 3
Recruiting
Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL
Condition
CTCL/ Mycosis Fungoides
Enrollment
80 pts
Location
United States
Sponsor
Soligenix
NCT06747949 Phase 3
Recruiting
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndro...
Condition
Sjögren's Syndrome
Enrollment
844 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
NCT06455085 N/A
Recruiting
RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE
Condition
Osteoporosis
Enrollment
2,634 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT05508906 Phase 1
Recruiting
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelis...
Condition
Metastatic Breast Cancer
Enrollment
190 pts
Location
United States, Australia
Sponsor
Olema Pharmaceuticals, Inc.
NCT06625385 N/A
Recruiting
A Study Evaluating the Safety and Efficacy of the 3M™ V.A.C. Peel and Place Dres...
Condition
Wound
Enrollment
90 pts
Location
United States
Sponsor
Solventum US LLC
NCT05462106 Phase 1, Phase 2
Recruiting
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down S...
Condition
Amyloid Plaque
Enrollment
176 pts
Location
United States, Spain, United Kingdom
Sponsor
AC Immune SA
NCT07174687 Phase 2
Recruiting
SGLT2 Inhibitors in Geographic Atrophy
Condition
Retinal Degeneration
Enrollment
70 pts
Location
United States
Sponsor
Washington University School o
NCT06835387 Phase 2
Recruiting
Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors
Condition
Small Bowel Adenocarcinoma
Enrollment
36 pts
Location
United States
Sponsor
Tiago Biachi de Castria
NCT04862221 Phase 2
Recruiting
TReatment for ImmUne Mediated PathopHysiology
Condition
Acute Liver Failure
Enrollment
163 pts
Location
United States
Sponsor
National Institute of Diabetes
NCT06702033 Phase 2
Recruiting
The Minimalist Trial-2
Condition
HPV-Related Oropharynx Squamous Cell Carcinoma
Enrollment
142 pts
Location
United States
Sponsor
Washington University School o
NCT06635148 Phase 2
Recruiting
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Part...
Condition
Geographic Atrophy
Enrollment
274 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
NCT04406818 N/A
Recruiting
Metabolic and Hemodynamic Reserve in Pediatric SCA
Condition
Child, Only
Enrollment
120 pts
Location
United States
Sponsor
Washington University School o
NCT03435796 Phase 2, Phase 3
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Condition
Neoplasms
Enrollment
1,541 pts
Location
United States, Australia, Austria
Sponsor
Celgene
NCT06078735 N/A
Recruiting
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibri...
Condition
Atrial Fibrillation
Enrollment
110 pts
Location
United States
Sponsor
Kansas City Heart Rhythm Resea
NCT06424288 Phase 3
Recruiting
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps Peop...
Condition
Heart Failure
Enrollment
6,000 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT05389215 Phase 2
Recruiting
Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With ...
Condition
Idiopathic Pulmonary Fibrosis
Enrollment
102 pts
Location
United States, South Korea
Sponsor
Daewoong Pharmaceutical Co. LT
NCT06023225 N/A
Recruiting
Sex Hormones, Postoperative Pain and Opioid Use
Condition
Postoperative Pain
Enrollment
210 pts
Location
United States
Sponsor
Washington University School o
NCT07110337 N/A
Recruiting
Diagnosing Epilepsy To EffeCT Change
Condition
Epilepsy
Enrollment
210 pts
Location
United States
Sponsor
Epiminder America, Inc.
NCT07016412 Phase 2
Recruiting
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Stud...
Condition
Chronic Obstructive Pulmonary Disease
Enrollment
480 pts
Location
United States
Sponsor
Verona Pharma plc
NCT07358364 N/A
Recruiting
Remibrutinib in Real-world Clinical Practice
Condition
Chronic Spontaneous Urticaria
Enrollment
3,280 pts
Location
United States
Sponsor
Novartis Pharmaceuticals
NCT06589245 Phase 1
Recruiting
Inhaled Ciclesonide Study in Preterm Infants
Condition
Bronchopulmonary Dysplasia
Enrollment
30 pts
Location
United States
Sponsor
Venkatesh Sampath
NCT04142177 N/A
Recruiting
Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response
Condition
Chronic Low Back Pain
Enrollment
2,529 pts
Location
United States
Sponsor
VA Office of Research and Deve